Insights · FDA

FDA articles.

Every article in our archive in FDA.

FDA· Sep 17, 2026

Home Use vs Hospital Device Cybersecurity Requirements

Home use vs hospital device cybersecurity: which controls the HDO environment provides, which the device must carry itself, and how the FDA reviews each case.

#FDA#Intended Use#Home Use Devices

Read article

FDA· Jul 30, 2026

Indications for Use, Predicates, and Cybersecurity Scope

How your Indications for Use statement and predicate choice change the cybersecurity scope of a 510(k): use environment, harm ceiling, pen test scope, and Special 510(k) eligibility.

#FDA#510(k)#Indications for Use

Read article

FDA· Jul 30, 2026

Breakthrough Device Designation and Cybersecurity

Breakthrough Device designation speeds FDA interaction but waives no cybersecurity requirement. Here is how Section 524B applies to Breakthrough devices in 2026.

#FDA#Breakthrough Devices#Section 524B

Read article

FDA· Jul 25, 2026

510(k) Cleared, No Postmarket Cybersecurity: Legal?

Cleared under Section 524B but skipping postmarket cybersecurity? Here's what statute, regs, and FDA enforcement actually say - across 510(k), De Novo, PMA, PDP, and HDE.

#FDA#Postmarket#Section 524B

Read article

FDA· Jul 23, 2026

Types of 510(k): Traditional, Special, Abbreviated

The three types of 510(k) - Traditional, Special, and Abbreviated - explained side by side, with the cybersecurity implications of each under Section 524B.

#FDA#510(k)#Traditional 510(k)

Read article

FDA· Jul 22, 2026

Q-Sub vs Pre-Sub: FDA Cybersecurity Guide

Q-Sub vs Pre-Sub for FDA cybersecurity: what they are, how they differ, and when to use a Pre-Submission to de-risk Section 524B threat models, SBOMs, and pen tests.

#FDA#Pre-Sub#Q-Sub

Read article

FDA· Jul 21, 2026

FDA SIR Cybersecurity Response: eSTAR Prep Guide

FDA Submission Issue Request (SIR) response strategy for cybersecurity: eSTAR prep checklist, common 524B gaps, and how to answer without restarting review.

#FDA#eSTAR#Cybersecurity

Read article

FDA· Jul 10, 2026

Medical Device Pen Testing: FDA vs EU MDR 2026

Medical device pen testing under FDA vs EU MDR: the 5 FDA report elements, MDR Annex I §17.2/17.4, and how one report serves both submissions.

#FDA#EU MDR#Penetration Testing

Read article

FDA· Jul 10, 2026

Mining FDA Databases for Cyber Precedent

A five-source workflow (510(k), De Novo, PMA, MAUDE, FOIA) for mining FDA cybersecurity precedent by product code before a Section 524B filing.

#FDA#510(k)#De Novo

Read article

FDA· Jun 18, 2026

SPDF and IEC 62304 Mapping: FDA Cyber

How SPDF activities map to IEC 62304 software lifecycle processes - the exact crosswalk FDA reviewers expect, where they overlap, and where 62304 falls.

#SPDF#IEC 62304#FDA

Read article

FDA· Jun 10, 2026

FDA IDE Cybersecurity Requirements: 2026

What the FDA's Feb 2026 guidance recommends for IDE cybersecurity: informed consent, architecture views, SBOM, labeling, and what's not required yet.

#Primer

Read article

FDA· Jun 3, 2026

SBOM Diffing & CVE Correlation Postmarket

How to operationalize SBOM diffing and CVE correlation across releases so postmarket vulnerability monitoring holds up under FDA Section 524B and the Feb.

#Primer

Read article

Ready when you are

Get FDA cleared without the cybersecurity headaches.

30-minute strategy session. No cost, no commitment - just answers from people who've shipped 275+ FDA submissions.